Manager × security

ROYCE & ASSOCIATES LP HAE holdings history

Who else holds this security? →

HAEMONETICS CORP/MASS · CUSIP 405024100 · CIK 906304

This is the oldest quarter open without an account, so changes against the quarter before it are withheld. Sign in to see them.
Citable facts

As of 2026-06-30, ROYCE & ASSOCIATES LP reported 71.47K HAE (shares), valued at $5.36M, or 0.04% of its reported non-derivative portfolio. Filed 2026-08-14.

Verify history & sources →
Portfolio weight and quantity history
Reported portfolio weight
0.04%
Shares
71.47K
71,475
Reported value
$5.36M
USD

Shares unchanged; reported value increased 33.07%, and weight changed +0.00 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.

Left: % · Right: Shares · Independently scaled axes

Exact data and methodology

Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.

QuarterWeightQuantitySource
Q2 20260.04%71,475SEC filing ↗Filed Aug 14, 2026Combination report
Q1 20260.04%71,475SEC filing ↗Filed May 12, 2026Combination report
Q4 20250.06%71,475SEC filing ↗Filed Feb 9, 2026Combination report
Q3 20250.34%701,242SEC filing ↗Filed Nov 12, 2025Combination report
Q2 20250.97%1,271,057SEC filing ↗Filed Aug 11, 2025Combination report
Q1 20250.80%1,161,296SEC filing ↗Filed May 6, 2025Combination report
Q4 20240.84%1,153,268SEC filing ↗Filed Feb 10, 2025Combination report
Q3 20240.88%1,210,546SEC filing ↗Filed Nov 6, 2024Combination report
Q2 20240.91%1,179,678SEC filing ↗Filed Aug 13, 2024Combination report
Q1 20240.96%1,266,614SEC filing ↗Filed May 13, 2024Combination report
Q4 20230.76%966,355SEC filing ↗Filed Feb 12, 2024Combination report
Q3 20230.86%947,550SEC filing ↗Filed Nov 9, 2023Combination report

History & evidence by quarter

QuarterWeightQuantityValueChange explainedSource
Q3 20230.86%947,550$84.88MThe prior quarter is outside the free window. Sign in for the comparison.SEC filing ↗
Filed Nov 9, 2023
Q4 20230.76%966,355$82.63MShares increased 1.98%; reported value decreased 2.65%, and weight changed -0.10 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 12, 2024
Q1 20240.96%1,266,614$108.11MShares increased 31.07%; reported value increased 30.83%, and weight changed +0.20 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 13, 2024
Q2 20240.91%1,179,678$97.59MShares decreased 6.86%; reported value decreased 9.72%, and weight changed -0.05 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 13, 2024
Q3 20240.88%1,210,546$97.30MShares increased 2.62%; reported value decreased 0.30%, and weight changed -0.03 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 6, 2024
Q4 20240.84%1,153,268$90.05MShares decreased 4.73%; reported value decreased 7.46%, and weight changed -0.04 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 10, 2025
Q1 20250.80%1,161,296$73.80MShares increased 0.70%; reported value decreased 18.04%, and weight changed -0.04 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 6, 2025
Q2 20250.97%1,271,057$94.83MShares increased 9.45%; reported value increased 28.50%, and weight changed +0.17 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 11, 2025
Q3 20250.34%701,242$34.18MShares decreased 44.83%; reported value decreased 63.96%, and weight changed -0.63 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 12, 2025
Q4 20250.06%71,475$5.73MShares decreased 89.81%; reported value decreased 83.24%, and weight changed -0.28 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 9, 2026
Q1 20260.04%71,475$4.03MShares unchanged; reported value decreased 29.68%, and weight changed -0.02 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 12, 2026
Q2 20260.04%71,475$5.36MShares unchanged; reported value increased 33.07%, and weight changed +0.00 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2026
ROYCE & ASSOCIATES LP · HAEMONETICS CORP/MASS

Take these holdings further.

This page includes 12 of 12 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.

  • Download CSV
  • Earlier quarters
  • Advanced screening & filtering
  • API & AI access
Already have an account?

+ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.

MCP  https://api.akkrudata.ai/mcp

get_institutional_portfolio
{"cik":"906304","quarter":"2026Q2","cusip":"405024100"}

get_institutional_manager_history
{"cik":"906304","page_size":100}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint
https://api.akkrudata.ai/mcp
API / MCP documentation
/documents
llms.txt
/llms.txt
Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

13F reports quarter-end long positions in securities traded on US exchanges, filed by managers holding at least $100 million of such securities; it is not the manager's full portfolio, not assets under management, and value changes are not returns. Weights use the reported total value as denominator. Option rows show notional value, not premium or net exposure. Amendments are merged into the quarter when Akkru could match them.